Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Comerica Bank

Comerica Bank cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 6.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,954 shares of the company’s stock after selling 1,212 shares during the quarter. Comerica Bank’s holdings in Henry Schein were worth $1,312,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Venturi Wealth Management LLC grew its position in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after purchasing an additional 569 shares during the last quarter. Quent Capital LLC boosted its position in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the last quarter. City State Bank acquired a new stake in Henry Schein during the fourth quarter worth approximately $55,000. Finally, Allworth Financial LP boosted its position in Henry Schein by 180.7% during the fourth quarter. Allworth Financial LP now owns 946 shares of the company’s stock worth $71,000 after acquiring an additional 609 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.08% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HSIC. StockNews.com lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. Barrington Research decreased their target price on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 6th. UBS Group decreased their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Finally, Piper Sandler cut their price target on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 30th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $79.30.

Henry Schein Stock Performance

Shares of HSIC stock opened at $68.68 on Monday. The company’s fifty day simple moving average is $67.59 and its 200-day simple moving average is $71.46. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.41 billion, a PE ratio of 28.26, a P/E/G ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter last year, the firm posted $1.10 EPS. The business’s revenue for the quarter was down .1% compared to the same quarter last year. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.